{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T23:25:25Z","timestamp":1787268325199,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000030","name":"U.S. Department of Health & Human Services | Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["75D30120C09322 AM002"],"award-info":[{"award-number":["75D30120C09322 AM002"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-74684-8","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T01:44:55Z","timestamp":1784339095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune correlates of risk for SARS-CoV-2 infection in children: a prospective, community-based cohort study"],"prefix":"10.1038","volume":"17","author":[{"given":"Katherine L.","family":"Hoffman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2000-5429","authenticated-orcid":false,"given":"Collrane","family":"Frivold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zack","family":"Acker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel S.","family":"Arnould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7093-4077","authenticated-orcid":false,"given":"Tara M.","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarina R.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Briggs-Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8332-8578","authenticated-orcid":false,"given":"Amanda","family":"Casto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2447-0504","authenticated-orcid":false,"given":"Sarah N.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2678-9310","authenticated-orcid":false,"given":"Mark","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenna","family":"Ehmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1134-4178","authenticated-orcid":false,"given":"Janet A.","family":"Englund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Gamboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7443-0527","authenticated-orcid":false,"given":"Alexander L.","family":"Greninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Grindstaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8579-032X","authenticated-orcid":false,"given":"Hanna","family":"Grioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Hatchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Hollcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Kuntz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie K.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Lockwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5594-3370","authenticated-orcid":false,"given":"Kaden D.","family":"McAllister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carter J.","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa P.","family":"MacMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5196-4713","authenticated-orcid":false,"given":"Claire M.","family":"Midgley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian D.","family":"Plumb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4425-7636","authenticated-orcid":false,"given":"Jonathan C.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sacha","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4567-8232","authenticated-orcid":false,"given":"Pavitra","family":"Roychoudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2870-5099","authenticated-orcid":false,"given":"Lea M.","family":"Starita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7565-2463","authenticated-orcid":false,"given":"Jeremy","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6170-4306","authenticated-orcid":false,"given":"Ana A.","family":"Weil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3527-1102","authenticated-orcid":false,"given":"Charles J.","family":"Wolock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Yetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2662-9427","authenticated-orcid":false,"given":"Peter B.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison L.","family":"Naleway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8502-9600","authenticated-orcid":false,"given":"Helen Y.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2106-0953","authenticated-orcid":false,"given":"Marco","family":"Carone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"key":"74684_CR1","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1093\/cid\/cis238","volume":"54","author":"SA Plotkin","year":"2012","unstructured":"Plotkin, S. A. & Gilbert, P. B. Nomenclature for immune correlates of protection after vaccination. Clin. Infect. Dis. 54, 1615\u20131617 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"74684_CR2","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1016\/j.vaccine.2008.06.012","volume":"26","author":"M Eichelberger","year":"2008","unstructured":"Eichelberger, M. et al. FDA\/NIH\/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007. Vaccine 26, 4299\u20134303 (2008).","journal-title":"Vaccine"},{"key":"74684_CR3","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1128\/CVI.00131-10","volume":"17","author":"SA Plotkin","year":"2010","unstructured":"Plotkin, S. A. Correlates of protection induced by vaccination. Clin. Vaccine Immunol. 17, 1055\u20131065 (2010).","journal-title":"Clin. Vaccine Immunol."},{"key":"74684_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126477","volume":"43","author":"D Amodio","year":"2024","unstructured":"Amodio, D. et al. Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference. Vaccine 43, 126477 (2024).","journal-title":"Vaccine"},{"key":"74684_CR5","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMra2206573","volume":"387","author":"DH Barouch","year":"2022","unstructured":"Barouch, D. H. Covid-19 vaccines - immunity, variants, boosters. N. Engl. J. Med. 387, 1011\u20131020 (2022).","journal-title":"N. Engl. J. Med."},{"key":"74684_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/imr.13091","volume":"310","author":"D Goldblatt","year":"2022","unstructured":"Goldblatt, D., Alter, G., Crotty, S. & Plotkin, S. A. Correlates of protection against SARS-CoV-2 infection and COVID-19 disease. Immunol. Rev. 310, 6\u201326 (2022).","journal-title":"Immunol. Rev."},{"key":"74684_CR7","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","volume":"27","author":"DS Khoury","year":"2021","unstructured":"Khoury, D. S. et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat. Med. 27, 1205\u20131211 (2021).","journal-title":"Nat. Med."},{"key":"74684_CR8","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1016\/j.vaccine.2021.05.063","volume":"39","author":"KA Earle","year":"2021","unstructured":"Earle, K. A. et al. Evidence for antibody as a protective correlate for COVID-19 vaccines. Vaccine 39, 4423\u20134428 (2021).","journal-title":"Vaccine"},{"key":"74684_CR9","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1038\/s41591-025-03908-z","volume":"31","author":"HY Chu","year":"2025","unstructured":"Chu, H. Y., Janes, H., Carone, M., Gilbert, P. B. & Plotkin, S. Improving the evidence base for COVID-19 vaccines. Nat. Med. 31, 3595\u20133596 (2025).","journal-title":"Nat. Med."},{"key":"74684_CR10","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1056\/NEJMp2211314","volume":"387","author":"PB Gilbert","year":"2022","unstructured":"Gilbert, P. B. et al. A Covid-19 milestone attained - A correlate of protection for vaccines. N. Engl. J. Med. 387, 2203\u20132206 (2022).","journal-title":"N. Engl. J. Med."},{"key":"74684_CR11","unstructured":"ModernaTX, Inc. Moderna COVID-19 Vaccine (2024\u20132025 Formula): Letter of Authorization. U.S. Food and Drug Administration; 2024. Available at: https:\/\/www.fda.gov\/media\/144636\/download."},{"key":"74684_CR12","doi-asserted-by":"publisher","first-page":"102058","DOI":"10.1016\/j.tmaid.2021.102058","volume":"41","author":"JJ Barboza","year":"2021","unstructured":"Barboza, J. J. et al. Assessment and management of asymptomatic COVID-19 infection: a systematic review. Travel Med. Infect. Dis. 41, 102058 (2021).","journal-title":"Travel Med. Infect. Dis."},{"key":"74684_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jmii.2020.05.001","volume":"54","author":"Z Gao","year":"2021","unstructured":"Gao, Z. et al. A systematic review of asymptomatic infections with COVID-19. J. Microbiol. Immunol. Infect. 54, 12\u201316 (2021).","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"74684_CR14","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3390\/vaccines9101195","volume":"9","author":"S Ramesh","year":"2021","unstructured":"Ramesh, S. et al. Emerging SARS-CoV-2 variants: a review of its mutations, its implications and vaccine efficacy. Vaccines (Basel) 9, 1195 (2021).","journal-title":"Vaccines (Basel)"},{"key":"74684_CR15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3390\/v14040653","volume":"14","author":"VR Flores-Vega","year":"2022","unstructured":"Flores-Vega, V. R. et al. SARS-CoV-2: evolution and emergence of new viral variants. Viruses 14, 653 (2022).","journal-title":"Viruses"},{"key":"74684_CR16","doi-asserted-by":"publisher","first-page":"101668","DOI":"10.1016\/j.xcrm.2024.101668","volume":"5","author":"WN Voss","year":"2024","unstructured":"Voss, W. N. et al. Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination. Cell Rep. Med. 5, 101668 (2024).","journal-title":"Cell Rep. Med."},{"key":"74684_CR17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S1473-3099(22)00801-5","volume":"23","author":"N Bobrovitz","year":"2023","unstructured":"Bobrovitz, N. et al. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression. Lancet Infect. Dis. 23, 556\u2013567 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"74684_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38275-1","volume":"14","author":"J Wei","year":"2023","unstructured":"Wei, J. et al. Protection against SARS-CoV-2 Omicron BA.4\/5 variant following booster vaccination or breakthrough infection in the UK. Nat. Commun. 14, 2799 (2023).","journal-title":"Nat. Commun."},{"key":"74684_CR19","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3390\/biomedicines11020370","volume":"11","author":"JR Spinardi","year":"2023","unstructured":"Spinardi, J. R. & Srivastava, A. Hybrid immunity to SARS-CoV-2 from infection and vaccination-evidence synthesis and implications for new COVID-19 vaccines. Biomedicines 11, 370 (2023).","journal-title":"Biomedicines"},{"key":"74684_CR20","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41591-023-02228-4","volume":"29","author":"DS Khoury","year":"2023","unstructured":"Khoury, D. S. et al. Predicting the efficacy of variant-modified COVID-19 vaccine boosters. Nat. Med. 29, 574\u2013578 (2023).","journal-title":"Nat. Med."},{"key":"74684_CR21","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1016\/S2666-5247(21)00267-6","volume":"3","author":"D Cromer","year":"2022","unstructured":"Cromer, D. et al. Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis. Lancet Microbe 3, e52\u2013e61 (2022).","journal-title":"Lancet Microbe"},{"key":"74684_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13052-024-01587-z","volume":"50","author":"C Luo","year":"2024","unstructured":"Luo, C., Chen, W., Cai, J. & He, Y. The mechanisms of milder clinical symptoms of COVID-19 in children compared to adults. Ital. J. Pediatr. 50, 28 (2024).","journal-title":"Ital. J. Pediatr."},{"key":"74684_CR23","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41591-021-01263-3","volume":"27","author":"YC Bartsch","year":"2021","unstructured":"Bartsch, Y. C. et al. Humoral signatures of protective and pathological SARS-CoV-2 infection in children. Nat. Med. 27, 454\u2013462 (2021).","journal-title":"Nat. Med."},{"key":"74684_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41590-020-00826-9","volume":"22","author":"SP Weisberg","year":"2021","unstructured":"Weisberg, S. P. et al. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat. Immunol. 22, 25\u201331 (2021).","journal-title":"Nat. Immunol."},{"key":"74684_CR25","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1001\/jamapediatrics.2020.1467","volume":"174","author":"R Castagnoli","year":"2020","unstructured":"Castagnoli, R. et al. Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatr. 174, 882\u2013889 (2020).","journal-title":"JAMA Pediatr."},{"key":"74684_CR26","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s43587-021-00114-7","volume":"1","author":"JM Bartleson","year":"2021","unstructured":"Bartleson, J. M. et al. SARS-CoV-2, COVID-19 and the ageing immune system. Nat. Aging 1, 769\u2013782 (2021).","journal-title":"Nat. Aging"},{"key":"74684_CR27","doi-asserted-by":"publisher","first-page":"108510","DOI":"10.1016\/j.clim.2020.108510","volume":"217","author":"M Kloc","year":"2020","unstructured":"Kloc, M., Ghobrial, R. M., Kuchar, E., Lewicki, S. & Kubiak, J. Z. Development of child immunity in the context of COVID-19 pandemic. Clin. Immunol. 217, 108510 (2020).","journal-title":"Clin. Immunol."},{"key":"74684_CR28","doi-asserted-by":"publisher","first-page":"e1405","DOI":"10.1002\/cti2.1405","volume":"11","author":"H Patel","year":"2022","unstructured":"Patel, H., McArdle, A., Seaby, E., Levin, M. & Whittaker, E. The immunopathogenesis of SARS-CoV-2 infection in children: diagnostics, treatment and prevention. Clin. Transl. Immunology 11, e1405 (2022).","journal-title":"Clin. Transl. Immunology"},{"key":"74684_CR29","doi-asserted-by":"publisher","first-page":"ofac554","DOI":"10.1093\/ofid\/ofac554","volume":"9","author":"L Tomasi","year":"2022","unstructured":"Tomasi, L. et al. Younger children develop higher effector antibody responses to SARS-CoV-2 infection. Open Forum Infect. Dis. 9, ofac554 (2022).","journal-title":"Open Forum Infect. Dis."},{"key":"74684_CR30","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1016\/j.cell.2023.08.044","volume":"186","author":"F Wimmers","year":"2023","unstructured":"Wimmers, F. et al. Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth. Cell 186, 4632\u20134651.e23 (2023).","journal-title":"Cell"},{"key":"74684_CR31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jinf.2023.06.018","volume":"87","author":"AC Dowell","year":"2023","unstructured":"Dowell, A. C. et al. Nucleocapsid-specific antibodies as a correlate of protection against SARS-CoV-2 reinfection in children. J. Infect. 87, 267\u2013269 (2023).","journal-title":"J. Infect."},{"key":"74684_CR32","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41591-024-02962-3","volume":"30","author":"Y Zhong","year":"2024","unstructured":"Zhong, Y. et al. Correlates of protection against symptomatic SARS-CoV-2 in vaccinated children. Nat. Med. 30, 1373\u20131383 (2024).","journal-title":"Nat. Med."},{"key":"74684_CR33","doi-asserted-by":"publisher","first-page":"e071446","DOI":"10.1136\/bmjopen-2022-071446","volume":"13","author":"TM Babu","year":"2023","unstructured":"Babu, T. M. et al. CASCADIA: a prospective community-based study protocol for assessing SARS-CoV-2 vaccine effectiveness in children and adults using a remote nasal swab collection and web-based survey design. BMJ Open 13, e071446 (2023).","journal-title":"BMJ Open"},{"key":"74684_CR34","doi-asserted-by":"publisher","first-page":"106436","DOI":"10.1016\/j.jinf.2025.106436","volume":"90","author":"CCA Noble","year":"2025","unstructured":"Noble, C. C. A. et al. Characterising the SARS-CoV-2 nucleocapsid (N) protein antibody response. J. Infect. 90, 106436 (2025).","journal-title":"J. Infect."},{"key":"74684_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ade9078","volume":"15","author":"D Benkeser","year":"2023","unstructured":"Benkeser, D. et al. Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial. Sci. Transl. Med. 15, eade9078 (2023).","journal-title":"Sci. Transl. Med."},{"key":"74684_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52348-9","volume":"15","author":"B Zhang","year":"2024","unstructured":"Zhang, B. et al. Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial. Nat. Commun. 15, 7954 (2024).","journal-title":"Nat. Commun."},{"key":"74684_CR37","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.1016\/S2666-5247(23)00012-5","volume":"4","author":"G Regev-Yochay","year":"2023","unstructured":"Regev-Yochay, G. et al. Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study. Lancet Microbe 4, e309\u2013e318 (2023).","journal-title":"Lancet Microbe"},{"key":"74684_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47429-8","volume":"15","author":"R Urschel","year":"2024","unstructured":"Urschel, R. et al. SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4\/5 COVID-19-vaccination in previously infected and non-infected individuals. Nat. Commun. 15, 3077 (2024).","journal-title":"Nat. Commun."},{"key":"74684_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39816-4","volume":"14","author":"T Hertz","year":"2023","unstructured":"Hertz, T. et al. Correlates of protection for booster doses of the SARS-CoV-2 vaccine BNT162b2. Nat. Commun. 14, 4575 (2023).","journal-title":"Nat. Commun."},{"key":"74684_CR40","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1038\/s41564-022-01262-1","volume":"7","author":"Y Fong","year":"2022","unstructured":"Fong, Y. et al. Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial. Nat. Microbiol. 7, 1996\u20132010 (2022).","journal-title":"Nat. Microbiol."},{"key":"74684_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1126\/science.abm3425","volume":"375","author":"P Gilbert","year":"2021","unstructured":"Gilbert, P. et al. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial. Science 375, 43\u201350 (2021).","journal-title":"Science"},{"key":"74684_CR42","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","volume":"27","author":"S Feng","year":"2021","unstructured":"Feng, S. et al. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nat. Med. 27, 2032\u20132040 (2021).","journal-title":"Nat. Med."},{"key":"74684_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35768-3","volume":"14","author":"Y Fong","year":"2023","unstructured":"Fong, Y. et al. Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial. Nat. Commun. 14, 331 (2023).","journal-title":"Nat. Commun."},{"key":"74684_CR44","doi-asserted-by":"publisher","first-page":"976382","DOI":"10.3389\/fimmu.2022.976382","volume":"13","author":"MW Keuning","year":"2022","unstructured":"Keuning, M. W. et al. Differences in systemic and mucosal SARS-CoV-2 antibody prevalence in a prospective cohort of Dutch children. Front. Immunol. 13, 976382 (2022).","journal-title":"Front. Immunol."},{"key":"74684_CR45","doi-asserted-by":"publisher","first-page":"ofaf006","DOI":"10.1093\/ofid\/ofaf006","volume":"12","author":"L Beeker","year":"2025","unstructured":"Beeker, L. et al. Correlates of protection against symptomatic COVID-19: The CORSER 5 case-control study. Open Forum Infect. Dis. 12, ofaf006 (2025).","journal-title":"Open Forum Infect. Dis."},{"key":"74684_CR46","first-page":"889","volume":"230","author":"MA Files","year":"2024","unstructured":"Files, M. A. et al. Kinetics and durability of antibody and T-cell responses to SARS-CoV-2 in children. J. Infect. Dis. 230, 889\u2013900 (2024).","journal-title":"J. Infect. Dis."},{"key":"74684_CR47","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1093\/bioinformatics\/bty407","volume":"34","author":"J Hadfield","year":"2018","unstructured":"Hadfield, J. et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics 34, 4121\u20134123 (2018).","journal-title":"Bioinformatics"},{"key":"74684_CR48","unstructured":"IQ-TREE. http:\/\/www.iqtree.org."},{"key":"74684_CR49","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1214\/20-EJS1740","volume":"14","author":"T Westling","year":"2020","unstructured":"Westling, T., van der Laan, M. J. & Carone, M. Correcting an estimator of a multivariate monotone function with isotonic regression. Electron. J. Stat. 14, 3032\u20133069 (2020).","journal-title":"Electron. J. Stat."},{"key":"74684_CR50","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1080\/10618600.2024.2304070","volume":"33","author":"CJ Wolock","year":"2024","unstructured":"Wolock, C. J., Gilbert, P. B., Simon, N. & Carone, M. A framework for leveraging machine learning tools to estimate personalized survival curves. J. Comput. Graph. Stat. 33, 1098\u20131108 (2024).","journal-title":"J. Comput. Graph. Stat."},{"key":"74684_CR51","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/infdis\/jiaf451","volume":"232","author":"M Carone","year":"2025","unstructured":"Carone, M., Wolock, C. J., Olivas-Martinez, A., Rotnitzky, A. & Gilbert, P. B. Immune correlates and vaccine immunobridging: statistical innovations, challenges, and opportunities. J. Infect. Dis. 232, 1024\u20131028 (2025).","journal-title":"J. Infect. Dis."},{"key":"74684_CR52","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. (R Foundation for Statistical Computing, 2023)."},{"key":"74684_CR53","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham, H. et al. Welcome to the tidyverse. J. Open Source Softw. 4, 1686 (2019).","journal-title":"J. Open Source Softw."},{"key":"74684_CR54","doi-asserted-by":"publisher","first-page":"570","DOI":"10.32614\/RJ-2021-053","volume":"13","author":"D Sjoberg","year":"2021","unstructured":"Sjoberg, D., Whiting, K., Curry, M., Lavery, J. & Larmarange, J. Reproducible summary tables with the gtsummary package. R J. 13, 570 (2021).","journal-title":"R J."},{"key":"74684_CR55","unstructured":"Schloerke, B. et al. GGally: Extension to \u2018ggplot2\u2019 (Comprehensive R Archive Network, 2024)."},{"key":"74684_CR56","unstructured":"Therneau, T. M. A Package for Survival Analysis in R. https:\/\/CRAN.R-project.org\/package=survival (2024)."},{"key":"74684_CR57","doi-asserted-by":"crossref","unstructured":"Wolock, C. survML: Tools for Flexible Survival Analysis Using Machine Learning (Comprehensive R Archive Network, 2024).","DOI":"10.32614\/CRAN.package.survML"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74684-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74684-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74684-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T23:04:10Z","timestamp":1787267050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74684-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74684"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74684-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.M.B. reported being on an advisory board for Sanofi. S.N.C. is an employee of Pfizer and may receive stock or stock options. J.A.E. reported consulting with AbbVie, Sanofi Pasteur, Moderna, Meissa Vaccines, AstraZeneca, and Pfizer, Inc. outside of the submitted work, and has received research funding from AstraZeneca, Merck, GlaxoSmithKline, Moderna, Shionogi, and Pfizer. A.L.G. reports contract testing to UW from Abbott, Cepheid, Novavax, Pfizer, Janssen, and Hologic, research support from Gilead, outside of the described work. J.L.K. reported research funding not related to the submitted work from Pfizer, Novartis, and Vir Biotechnology. C.M.L. reported being on the Scientific Advisory Board for LGC group. I.D.P. is an employee of Pfizer and may receive stock or stock options; contribution to this work was part of a previous affiliation. P.R. reported contract to UW from Aicuris and honoraria from the Gates Discovery Center not related to the submitted work. A.A.W. reported research funding not related to the submitted work from Pfizer. P.B.G. reported consulting with MinervaX and Curevo, and membership on vaccine scientific advisory boards for MinervaX, Curevo, Sanofi, Moderna, and AstraZeneca, outside of the submitted work, and has received research funding from Sanofi (contract to institution). H.Y.C. has served on advisory boards for Roche, Vir, and Merck. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8779"}}